MR 4.5
Showing 26 - 50 of >10,000
Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)
Active, not recruiting
- Chronic Myeloid Leukemia
-
Los Angeles, California
- +61 more
Mar 17, 2022
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction
Not yet recruiting
- Clinical Stage I Gastric Cancer AJCC v8
- +9 more
- Atezolizumab
- +12 more
- (no location specified)
Apr 26, 2023
An Imaging Agent With Positron Emission Tomography/Magnetic
Recruiting
- Recurrent Soft Tissue Sarcoma
- +2 more
- Fluorodopa F 18
- +4 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 4, 2023
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Not yet recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +10 more
- Carboplatin
- +9 more
- (no location specified)
Jan 31, 2023
Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial
Not yet recruiting
- Recurrent Biliary Tract Carcinoma
- +13 more
- Binimetinib
- +10 more
- (no location specified)
Nov 8, 2022
MDD Trial in Toronto (MR-guided Focused Ultrasound)
Recruiting
- Major Depressive Disorder
- MR-guided Focused Ultrasound
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Mar 15, 2021
Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Locally Advanced Malignant Solid Neoplasm
- Binimetinib
- +22 more
- (no location specified)
Dec 2, 2022
Essential Tremor Trial in Worldwide (Transcranial ExAblate, Sham Transcranial ExAblate)
Active, not recruiting
- Essential Tremor
- Transcranial ExAblate
- Sham Transcranial ExAblate
-
Stanford, California
- +7 more
Mar 29, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Not yet recruiting
- Metastatic Colon Adenocarcinoma
- +6 more
- Balstilimab
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 17, 2022
Glioma, Metastatic Brain Cancer Trial in Toronto (ExAblate Transcranial System)
Active, not recruiting
- Glioma
- Metastatic Brain Cancer
- ExAblate Transcranial System
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Sep 7, 2021
Alzheimer Trial in Toronto (Blood Brain Barrier (BBB) Disruption)
Recruiting
- Alzheimer Disease
- Blood Brain Barrier (BBB) Disruption
-
Toronto, Ontario, CanadaDivision of Neurosurgery, Sunnybrook Health Sciences Centre
Oct 8, 2021
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States
Recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +7 more
-
Aurora, Colorado
- +7 more
Nov 29, 2022
PET/MR in Post Stroke Cardiac Inflammation Study
Recruiting
- Stroke
- Inflammation
- cardiac PET/MRI
- +2 more
-
London, Ontario, CanadaHeart & Brain Lab, Western University
Mar 17, 2023
Stage III Uterine Corpus Leiomyosarcoma AJCC v8, Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 Trial in United States (Computed
Active, not recruiting
- Stage III Uterine Corpus Leiomyosarcoma AJCC v8
- Stage IV Uterine Corpus Leiomyosarcoma AJCC v8
- Computed Tomography
- +4 more
-
Phoenix, Arizona
- +14 more
Aug 23, 2022
Prostate Cancer Trial in Toronto (MR-guided Radiotherapy Boost)
Not yet recruiting
- Prostate Cancer
- MR-guided Radiotherapy Boost
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Hospital
Oct 6, 2022
Real-time Tumor Localization and Guidance for Radiotherapy Using
Recruiting
- Tumor, Solid
- 4D Planar US Transducer
-
Madison, WisconsinUniversity of Wisconsin, Madison
Nov 8, 2022
Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR
Completed
- Healthy
- Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
- +2 more
-
Cairo, EgyptGenuine Research Center GRC
Mar 2, 2023
Healthy Trial in Nottingham (Ref (TF2), Evobrutinib MR-T1, Evobrutinib MR-T2)
Recruiting
- Healthy
- Ref (TF2)
- +8 more
-
Nottingham, United KingdomQuotient Clinical Ltd
Jul 11, 2022
Breast Cancer Trial in Toronto (IMRT + CT + MR scan)
Active, not recruiting
- Breast Cancer
- IMRT + CT + MR scan
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Oct 6, 2022
Advanced Solid Tumors Trial in Guangzhou (MR001)
Not yet recruiting
- Advanced Solid Tumors
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Nov 12, 2023
Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Biospecimen Collection
- +19 more
- (no location specified)
Jan 6, 2023
Head Neck Cancer Trial (SBRT on the MR-Linac)
Not yet recruiting
- Head and Neck Cancer
- SBRT on the MR-Linac
- (no location specified)
May 3, 2022
MR Evidence of Cardiac Inflammation Post-Stroke
Recruiting
- Stroke, Ischemic
- +2 more
- Gadolinium-enhanced cardiac MRI
- +2 more
-
London, Ontario, CanadaHeart & Brain Lab, Western University
Feb 8, 2023
3T MR for Secondary Hyperparathyroidism Comparison With 4DCT
Not yet recruiting
- Parathyroid Gland Disease
- Secondary Hyperparathyroidism
- (no location specified)
Sep 15, 2022
MR Guidance for Liver and Pancreas
Recruiting
- Magnetic Resonance Imaging
- MRI
-
Toronto, Ontario, CanadaUniversity Health Network - Princess Margaret Cancer Centre
Oct 6, 2022